Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Myeloproliferative Neoplasms
•
Hematology
•
Benign Hematology
What genetic testing should be done for a patient with polycythemia/erythrocytosis with family history of similar findings?
JAK mutations negative
Related Questions
How do you manage patients with embolic stroke of an undetermined source and a papillary fibroelastoma found on an echocardiogram?
How would you treat a young woman with refractory ITP surrounding pregnancy who responds to fostamatinib?
For an asymptomatic patient discovered during workup for elevated PT/PTT to have mild prothrombin deficiency, would you suggest any preoperative prophylaxis?
In which cases would you consider early transition to DOAC (within 72 hours) for hospitalized patients with intermediate or high risk PE?
For patients with a JAK2 positive myeloproliferative neoplasm, do you always perform a bone marrow biopsy at diagnosis?
In which patients with essential thrombocythemia would you use ropeginterferon alfa-2b?
How do you treat factor XI deficient patients with surgery or trauma related bleeding?
In what situations would you consider ESAs in hospitalized patients with severe anemia for indications other than CKD or myelosuppressive chemotherapy (e.g., ACD, hemorrhage)?
Are SCDs contraindicated in patients with acute DVTs?
Would you treat a hemochromatosis carrier with IV iron if they have iron deficiency anemia in conjunction with elevated ferritin?